H. Karasuyama, K. Miyake, S. Yoshikawa, and Y. Yamanishi, Multifaceted roles of basophils in health and disease, J Allergy Clin Immunol, vol.142, pp.370-380, 2018.

H. Pere, C. Tanchot, J. Bayry, M. Terme, J. Taieb et al., Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer, Oncoimmunology, vol.1, pp.326-333, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02455552

M. Romano, G. Fanelli, C. J. Albany, G. Giganti, and L. G. Past, Present, and future of regulatory T cell therapy in transplantation and autoimmunity, Front Immunol, vol.10, p.43, 2019.

J. B. Wing, A. Tanaka, and S. Sakaguchi, Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer, Immunity, vol.50, pp.302-316, 2019.

M. Sharma, M. Das, E. Stephen-victor, C. Galeotti, A. Karnam et al., Regulatory T cells induce activation rather than suppression of human basophils, Sci Immunol, vol.3, p.829, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01817714

E. Stephen-victor, M. Das, M. Sharma, C. Galeotti, H. Fohrer-ting et al., Demystification of enigma on antigen-presenting cell features of human basophils: data from secondary lymphoid organs, Haematologica, vol.102, pp.233-237, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01471780

L. De-monte, M. Reni, E. Tassi, D. Clavenna, I. Papa et al., Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer, J Exp Med, vol.208, pp.469-478, 2011.

L. De-monte, S. Wörmann, E. Brunetto, S. Heltai, G. Magliacane et al., Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients, Cancer Res, vol.76, pp.1792-1803, 2016.

S. K. Bromley, T. R. Mempel, and A. D. Luster, Orchestrating the orchestrators: chemokines in control of T cell traffic, Nat Immunol, vol.9, pp.970-980, 2008.

F. Li, M. K. Sutherland, C. Yu, R. B. Walter, L. Westendorf et al., Characterization of SGN-CD123A, A potent CD123-directed antibody-drug conjugate for acute myeloid leukemia, Mol Cancer Ther, vol.17, pp.554-564, 2018.